Rafael Gomes/LinkedIn
                         
                                                                  Sep 12, 2025, 05:33 
                                
                                Rafael Gomes Highlights Key ESC 2025 CABG Findings: Aspirin Monotherapy Still Best After Surgery
Rafael Gomes, Cardiologist at Real Hospital Português, posted on LinkedIn:
”European Society of Cardiology Congress 2025 – Hotline 10: CABG and beyond
- NEWTON-CABG CardioLink-5 (Canada, multicenter RCT)
Evolocumab (PCSK9 inhibitor) did not improve saphenous vein graft (SVG) patency at 24 months after CABG. Despite a ~48% LDL-C reduction, SVG disease remained similar (21.7% vs 19.7%, p=0.44).
Takeaway: vein graft failure is likely more driven by thrombosis, remodeling, and inflammation than by LDL-C levels alone. - TACSI Trial (Nordic registry-based RCT)
In ACS patients undergoing CABG, 12 months of DAPT (aspirin + ticagrelor) was not superior to aspirin alone for preventing MACE (4.8% vs 4.6%). Major bleeding was more frequent with DAPT (4.9% vs 2.0%).
Takeaway: aspirin monotherapy remains the safest strategy post-CABG in ACS. - TOP-CABG (China, large trial)
Compared early intensive statin therapy vs standard initiation after CABG. Intensive early statin initiation showed modest improvement in lipid lowering, but no significant differences in major graft or clinical outcomes at 1 year.
Takeaway: timing of statin initiation may be less important than long-term adherence. - OPINION Trial – 1-year outcomes (China, multicenter RCT)
Compared off-pump vs on-pump CABG. At 1 year, no significant differences in death, MI, stroke, or repeat revascularization between strategies.
Takeaway: both surgical techniques remain acceptable, with outcomes driven more by surgical expertise and patient selection. - Key message: In CABG patients, simpler strategies often prevail:
• PCSK9 inhibition did not rescue SVG patency (NEWTON-CABG).
• DAPT offered no net benefit over aspirin (TACSI).
• Early statin timing and surgical technique (TOP-CABG & OPINION) did not alter short-term outcomes significantly. 
Ongoing follow-up will clarify whether longer-term differences emerge, but for now, evidence supports aspirin monotherapy, consistent statin therapy, and tailored surgical approach as the mainstays of post-CABG care.”
Stay updated with Hemostasis Today.
                                                                        Aspirin
                                                                            CABG
                                                                            Cardiology
                                                                            Coronary artery bypass grafting
                                                                            ESC 2025
                                                                            European Society of Cardiology
                                                                            European Society of Cardiology Congress 2025
                                                                            Evolocumab
                                                                            Health
                                                                            Hematology
                                                                            Hemostasis
                                                                            Hemostasis Today
                                                                            Medicine
                                                                            NEWTON-CABG CardioLink-5
                                                                            OPINION Trial
                                                                            PCSK9 inhibitor
                                                                            Rafael Gomes
                                                                            Real Hospital Português
                                                                            Saphenous Vein Graft
                                                                            SVG
                                                                            TACSI Trial
                                                                            thrombosis
                                                                
                        - 
                    Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
 - 
                    Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
 - 
                    Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
 - 
                    Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
 - 
                    Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
 
- 
                    Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
 - 
                    Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
 - 
                    Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
 - 
                    Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
 - 
                    Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
 
- 
                    Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
 - 
                    Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
 - 
                    Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
 - 
                    Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
 - 
                    Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
 
- 
                    Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
 - 
                    Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
 - 
                    Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
 - 
                    Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
 - 
                    Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry
 
Nov 3, 2025, 09:13 
                        
                    Nov 3, 2025, 08:23 
                        
                    Nov 3, 2025, 07:10 
                        
                    Nov 3, 2025, 04:56 
                        
                    